edoc

Anti-IL-5 (mepolizumab) therapy does not alter IL-5 receptor alpha levels in patients with eosinophilic esophagitis

Conus, S. and Straumann, A. and Simon, H. U.. (2009) Anti-IL-5 (mepolizumab) therapy does not alter IL-5 receptor alpha levels in patients with eosinophilic esophagitis. Journal of allergy and clinical immunology, Vol. 123, H. 1 , S. 269 ; author reply 269-270.

Full text not available from this repository.

Official URL: http://edoc.unibas.ch/dok/A6007957

Downloads: Statistics Overview


Faculties and Departments:03 Faculty of Medicine > Bereich Medizinische Fächer (Klinik) > Gastroenterologie
03 Faculty of Medicine > Departement Klinische Forschung > Bereich Medizinische Fächer (Klinik) > Gastroenterologie
UniBasel Contributors:Straumann, Alex
Item Type:Article, refereed
Article Subtype:Further Journal Contribution
Bibsysno:Link to catalogue
Publisher:Mosby
ISSN:0091-6749
Note:Publication type according to Uni Basel Research Database: Journal item
Related URLs:
Identification Number:
Last Modified:18 Jul 2014 09:10
Deposited On:18 Jul 2014 09:10

Repository Staff Only: item control page